|
Ron Haak, Ph.D. brings 30 years of research and development experience to Alvine, most recently as a consultant to start-ups and Fortune 500 companies as well as to the Institute for OneWorld Health, a nonprofit pharmaceutical company focused on developing medicines for diseases of poverty. Prior to becoming a consultant in 2002, he was a Principal Scientist and Senior Vice President, Technology Development at ALZA Corporation, where he spent 15 years as a senior scientist and executive during its growth and ultimate merger with Johnson & Johnson. During his tenure as a Vice President, he was responsible for key aspects of several new drug applications and successfully took new drug delivery technologies from concept to product launch. Prior to that, he was a senior researcher at the Rockwell International Science Center for nine years. He received his Ph.D. in Chemistry from the University of California, Santa Barbara. | 